Codexis Inc. (CDXS) Shares on the Decline: Short-term Analysis

Currently, Codexis Inc. [CDXS] is trading at $1.94, down -7.62%. An important factor to consider is whether the stock is rising or falling in short-term value. The CDXS shares have gain 12.79% over the last week, with a monthly amount glided 13.45%, and seem to be holding up well over a long-time horizon.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


On 12, September 2023, Codexis to Participate in Cantor Global Healthcare Conference. In a post published today on Yahoo Finance, Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare Conference, being held September 26-28, 2023, in New York, New York.

From an analyst’s perspective:

Codexis Inc. [NASDAQ: CDXS] stock has seen the most recent analyst activity on August 07, 2023, when TD Cowen downgraded its rating to a Market Perform and also revised its price target to $4 from $21.

This stock has fluctuated between a low of $1.58 and a high of $7.80 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $7.71 within the next 12 months. Codexis Inc. [NASDAQ: CDXS] shares were valued at $1.94 at the most recent close of the market. An investor can expect a potential return of 297.42% based on the average CDXS price forecast.

Analyzing the CDXS fundamentals

Recent quarter sales for Codexis Inc. [NASDAQ:CDXS] were 21.32 billion which represents -44.50% decline. The company generates $558,831 in revenue per employee, while its income per employee is -$135,452. Gross Margin for this corporation currently stands at +68.66% with Operating Margin at -22.88%, Pretax Margin comes in at -24.04%, and Net Margin reading is -24.24%. To continue investigating profitability, this company’s Return on Assets is posted at -13.52, Equity is -21.73, Total Capital is -15.84, and Invested Capital is -17.18. An extended look at the Principal structure reveals enduring liabilities to the total capital of 23.16 and enduring liabilities to assets of 17.43.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8367 points at the first support level, and at 1.7333 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.0967, and for the 2nd resistance point, it is at 2.2533.

Codexis Inc. [CDXS] reported earnings per share of -$0.17 for its fiscal quarter that ended on 6/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.21/share, meaning a difference of $0.04 and a surprise factor of 19.00%. By comparison, the stated earnings for the previous quarter ended on 3/30/2023 were -$0.34 per share as compared to estimates of -$0.31 per share, a difference of -$0.03 representing a surprise of -9.70%.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Codexis Inc. [NASDAQ:CDXS] is 3.40. On the other hand, the Quick Ratio is 3.28, and the Cash Ratio is 2.33. Considering the valuation of this stock, the price to sales ratio is 2.20, the price to book ratio is 2.12.

Transactions by insiders

Recent insider trading involved Norrett Kevin, Chief Operating Officer, that happened on Sep 11 when 9000.0 shares were purchased. , DILLY STEPHEN GEORGE completed a deal on Sep 08 to buy 58479.0 shares. Meanwhile, Fitzgerald Margaret Nell bought 11834.0 shares on Sep 08.